Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of ASP4070 in cedar pollinosis
NCT03101267Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ASP4070 in Japanese cedar pollinosis[1][3], sponsored by Astellas Pharma. Started Apr 2017; status: completed.
02
Drugs
ASP4070
03
Conditions
Japanese cedar pollinosis[1][3]
Beyond the preview
Go deeper on NCT03101267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03101267.